Sep 9, 2026 07:01AM
Sep 9, 2026 07:00AM
Aug 14, 2026 07:00AM
Aug 14, 2026 07:00AM
Aug 13, 2026 08:30AM
Jul 10, 2026 06:52AM
Jul 9, 2026 08:30AM Fate Therapeutics gets FDA clearance for FT839 CAR T-cell candidate
Jul 9, 2026 08:30AM
Jul 6, 2026 08:31AM
Jul 6, 2026 08:30AM
Jun 12, 2026 08:10AM
Jun 4, 2026 08:32AM
Jun 4, 2026 08:30AM
Jun 1, 2026 08:30AM Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting
May 21, 2026 08:32AM
May 21, 2026 08:30AM
May 13, 2026 08:30AM
May 11, 2026 08:31AM
May 11, 2026 08:30AM
May 5, 2026 08:31AM
May 5, 2026 08:30AM Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819
May 4, 2026 09:00AM
Apr 30, 2026 09:00AM
Mar 18, 2026 11:30AM
Feb 26, 2026 09:00AM
Jan 23, 2026 12:56PM
Dec 21, 2025 04:00AM
Dec 8, 2025 08:00AM Fate Therapeutics reports FT819 lupus trial progress at ASH meeting
Dec 8, 2025 08:00AM
Oct 27, 2025 12:29AM
Oct 26, 2025 11:30AM
Sep 3, 2025 06:20AM
Aug 12, 2025 04:01PM
Jun 11, 2025 01:00PM
Jun 11, 2025 09:02AM Fate Therapeutics (FATE) Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis
Jun 11, 2025 09:00AM
May 13, 2025 04:01PM
Apr 14, 2025 08:01AM
Apr 14, 2025 08:00AM
Mar 6, 2025 05:19AM
Mar 5, 2025 04:01PM
Jan 2, 2025 04:00PM Biotech outlook for 2025: Stifel
Nov 12, 2024 04:01PM
Aug 13, 2024 04:05PM
May 9, 2024 04:01PM
May 9, 2024 08:38AM
May 9, 2024 08:30AM
Nov 8, 2023 04:01PM
Aug 8, 2023 04:01PM Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
May 3, 2023 04:01PM

330,654 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All